Tru Independence LLC Gilead Sciences, Inc. Transaction History

Tru Independence LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 20, 2021	SELL	$60.0 - $68.46 $46,320 - $52,851	-772 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$56.65 - $64.55 $1,246 - $1,420	22 Added 2.93%	772 $44,000
Q3 2020 Nov 19, 2020	SELL	$62.1 - $78.08 $6.94 Million - $8.73 Million	-111,833 Reduced 99.33%	750 $47,000
Q2 2020 Aug 19, 2020	SELL	$72.34 - $84.0 $1.67 Million - $1.94 Million	-23,073 Reduced 17.01%	112,583 $8.66 Million
Q4 2019 May 19, 2020	BUY	$61.62 - $67.78 $8.36 Million - $9.19 Million	135,656 New	135,656 $10.1 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.